Myriad Genetics Inc.
MYGN | NASDAQ
$4.01
+$0.12 (+3.08%)
At close: Sep 21, 2026, 4:00 PM ET
$3.97
-$0.04 (-1.00%)
Pre-market:
Sep 22, 2026, 9:13 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 806.6M | 829M | 824.5M | 825.3M | 832.9M | 831.3M | 837.6M | 823.6M | 802.2M | 774.2M | 753.2M | 734.4M | 698.9M | 694.7M | 678.4M | 661.4M | 672.3M | 682.4M | 690.6M | 529.8M | 507.7M | 411.5M |
Cost of Revenue | 251.4M | 249M | 247.9M | 244.6M | 246.2M | 249.3M | 252.2M | 254.1M | 248.2M | 241.6M | 236.2M | 228.5M | 221.3M | 213.2M | 202M | 193.9M | 191.3M | 195.3M | 197.6M | 151.8M | 148.2M | 131.2M |
Gross Profit | 555.2M | 580M | 576.6M | 580.7M | 586.7M | 582M | 585.4M | 569.5M | 554M | 532.6M | 517M | 505.9M | 477.6M | 481.5M | 476.4M | 467.5M | 481M | 487.1M | 493M | 378M | 359.5M | 280.3M |
Operating Income | -93.2M | -383.5M | -387.2M | -420.5M | -417.2M | -124.5M | -123.4M | -115.8M | -155.9M | -233.1M | -257.4M | -272M | -256.9M | -161M | -123.7M | -120.8M | -155.7M | -158.7M | -190.5M | -147.4M | -107.1M | -154.6M |
Interest Income | 2.4M | 2.2M | 1.8M | 1.3M | 1.2M | 1.4M | 1.7M | 2.1M | 2.3M | 2.4M | 2.5M | 2.8M | 3.3M | 3.2M | 2.6M | 1.7M | 800K | 600K | 700K | 900K | 1.1M | 1.4M |
Pretax Income | -111.8M | -399.8M | -395.1M | -425.3M | -420.3M | -126.9M | -123.4M | -116.6M | -156.6M | -235.5M | -262.2M | -282M | -265M | -166.8M | -140.6M | -132M | -48M | -33.9M | -57.1M | -13.6M | -97.1M | -151.8M |
Net Income | -112.6M | -399.9M | -365.9M | -400.5M | -395.2M | -101.4M | -127.3M | -116M | -155.2M | -234.6M | -263.3M | -274.4M | -248.2M | -146.2M | -112M | -77.3M | -17.6M | -8.2M | -27.2M | -19.6M | -59.4M | -110.1M |
Selling & General & Admin | 539.9M | 537.7M | 537.6M | 549.3M | 549.5M | 555.7M | 560.6M | 457.2M | 454.2M | 450M | 461.1M | 575M | 569.4M | 555.8M | 514.7M | 509.7M | 559.4M | 567.1M | 602M | 460.5M | 404.4M | 377M |
Research & Development | 105.8M | 106.4M | 106.8M | 113.5M | 113.8M | 115.3M | 112.7M | 101.5M | 97M | 91.1M | 88.7M | 91.1M | 87.6M | 86.7M | 85.4M | 78.6M | 76.9M | 76.1M | 78M | 61.4M | 60.2M | 58.1M |
Other Expenses | 2.7M | 319.4M | 319.4M | 338.4M | 340.6M | 35.5M | 35.5M | 126.6M | 158.7M | 224.6M | 224M | 111.2M | 76.9M | -600K | n/a | -100K | -100K | -100K | -200K | -100K | -100K | -100K |
Operating Expenses | 648.4M | 963.5M | 963.8M | 1B | 1B | 706.5M | 708.8M | 685.3M | 709.9M | 765.7M | 774.4M | 777.9M | 734.5M | 642.5M | 600.1M | 588.3M | 636.3M | 643.2M | 680M | 521.9M | 464.6M | 435.1M |
Interest Expense | 8.2M | 13.8M | 10.5M | 6.8M | 3.8M | 3.1M | 2.8M | 3M | 3.2M | 2.9M | 2.9M | 2.9M | 2.7M | 2.8M | 3.2M | 2.8M | 3.1M | 4.5M | 6.6M | 9M | 10.8M | 11.9M |
Selling & Marketing Expenses | 296.4M | 285.2M | 280.8M | 496.2M | 425.2M | 426.1M | 426.3M | 142.2M | 142.2M | -8.1M | -77.5M | -77.5M | -77.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 899.8M | 1.21B | 1.21B | 1.25B | 1.25B | 955.8M | 961M | 939.4M | 958.1M | 1.01B | 1.01B | 1.01B | 955.8M | 855.7M | 802.1M | 782.2M | 827.6M | 838.5M | 877.6M | 673.7M | 612.8M | 566.3M |
Income Tax Expense | 800K | 100K | -29.2M | -24.8M | -25.1M | -25.5M | 3.9M | -600K | -1.4M | -900K | 1.1M | -7.6M | -16.8M | -20.6M | -28.6M | -54.7M | -30.4M | -25.7M | -29.9M | 6M | -37.7M | -41.6M |
Shares Outstanding (Basic) | 94.8M | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.73M | 81.7M | 81.3M | 81.5M | 80.7M | 78.33M | 78.85M | 76.14M | 78.8M | 77.2M | 75.96M |
Shares Outstanding (Diluted) | 94.8M | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.9M | 81.7M | 81.3M | 81.5M | 80.7M | 80.4M | 80.1M | 79.9M | 81.5M | 77.2M | 76M |
EPS (Basic) | -1.19 | -4.30 | -3.95 | -4.33 | -4.28 | -1.12 | -1.41 | -1.30 | -1.81 | -2.82 | -3.20 | -3.36 | -3.04 | -1.80 | -1.39 | -0.97 | -0.23 | -0.11 | -0.37 | -0.86 | -1.37 | -2.05 |
EPS (Diluted) | -1.19 | -4.30 | -3.95 | -4.33 | -4.28 | -1.12 | -1.41 | -1.30 | -1.81 | -2.82 | -3.20 | -3.36 | -3.04 | -1.80 | -1.39 | -0.97 | -0.24 | -0.12 | -0.38 | -0.87 | -1.37 | -2.05 |
EBITDA | -58.1M | -334.2M | -330.9M | -362.6M | -357.6M | -63.9M | -59.4M | -52.1M | -93.4M | -174.4M | -197.4M | -212.4M | -196.6M | -98.7M | -67.8M | -66.2M | 19.6M | 41.3M | 15.8M | 63.6M | -16.1M | -71.1M |
EBIT | -56.9M | -386M | -384.6M | -418.5M | -416.5M | -123.8M | -120.6M | -113.6M | -153.4M | -232.6M | -259.4M | -274M | -257.2M | -158.9M | -121.6M | -118.7M | -34.4M | -18.9M | -50.6M | -7.5M | -48.4M | -46.6M |
Depreciation & Amortization | 37.7M | 51.8M | 53.7M | 55.9M | 58.9M | 59.9M | 61.2M | 61.5M | 60M | 58.2M | 62M | 61.6M | 60.6M | 60.2M | 53.8M | 52.4M | 53.5M | 57.5M | 62.8M | 67.6M | 71.1M | 71.9M |
Add to Watchlist
Select watchlists to add or remove MYGN